Literature DB >> 19484645

Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Kevin Duff1, Leigh J Beglinger, Danielle Theriault, Jessica Allison, Jane S Paulsen.   

Abstract

Huntington's disease (HD) is associated with a variety of cognitive deficits, as well as motor and psychiatric disturbances. As clinical trials for HD evolve, briefer screening instruments will be needed to determine cognitive effects of interventions. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) may fill this gap. A total of 75 participants diagnosed with HD were evaluated with the RBANS, as well as several other scales typically used in HD. RBANS performances for these participants fell significantly below expectations for the Total Scale score, all five Indexes, and 11 of the 12 individual subtests. Cognitive scores on the RBANS were also significantly related to other markers of HD, including motor abnormalities, functional abilities, and other cognitive scores. Although additional research is needed, the current study supports the clinical applicability of the RBANS in patients with HD.

Entities:  

Mesh:

Year:  2009        PMID: 19484645      PMCID: PMC2854844          DOI: 10.1080/13803390902926184

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  41 in total

1.  The relation of the trail making test to organic brain damage.

Authors:  R M REITAN
Journal:  J Consult Psychol       Date:  1955-10

2.  A meta-analytic review of verbal fluency deficits in Huntington's disease.

Authors:  Julie D Henry; John R Crawford; Louise H Phillips
Journal:  Neuropsychology       Date:  2005-03       Impact factor: 3.295

3.  Longitudinal change in basal ganglia volume in patients with Huntington's disease.

Authors:  E H Aylward; Q Li; O C Stine; N Ranen; M Sherr; P E Barta; F W Bylsma; G D Pearlson; C A Ross
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

4.  White matter volume and cognitive dysfunction in early Huntington's disease.

Authors:  Leigh J Beglinger; Peg C Nopoulos; Ricardo E Jorge; Douglas R Langbehn; Ania E Mikos; David J Moser; Kevin Duff; Robert G Robinson; Jane S Paulsen
Journal:  Cogn Behav Neurol       Date:  2005-06       Impact factor: 1.600

5.  Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task.

Authors:  M J Roman; D C Delis; J V Filoteo; T L Demadura; J Paulsen; N R Swerdlow; M R Swenson; D Salmon; N Butters; C Shults
Journal:  J Clin Exp Neuropsychol       Date:  1998-12       Impact factor: 2.475

6.  Utility of clinical trial batteries in the measurement of Alzheimer's and Huntington's dementia.

Authors:  E Mohr; D Walker; C Randolph; M Sampson; T Mendis
Journal:  Int Psychogeriatr       Date:  1996       Impact factor: 3.878

7.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

8.  Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias.

Authors:  J V Filoteo; D C Delis; M J Roman; T Demadura; E Ford; N Butters; D P Salmon; J Paulsen; C W Shults; M Swenson
Journal:  J Clin Exp Neuropsychol       Date:  1995-10       Impact factor: 2.475

9.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

10.  The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy.

Authors:  A E Rosser; J R Hodges
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

View more
  13 in total

1.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

2.  Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Dana McDermott; Dan Luong; Christopher Randolph; Adam L Boxer
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-04       Impact factor: 2.475

3.  RBANS Validity Indices: a Systematic Review and Meta-Analysis.

Authors:  Robert D Shura; Timothy W Brearly; Jared A Rowland; Sarah L Martindale; Holly M Miskey; Kevin Duff
Journal:  Neuropsychol Rev       Date:  2018-05-16       Impact factor: 7.444

4.  Clinical predictors of driving status in Huntington's disease.

Authors:  Leigh J Beglinger; Luke Prest; James A Mills; Jane S Paulsen; Megan M Smith; Pedro Gonzalez-Alegre; Kelly C Rowe; Peggy Nopoulos; Ergun Y Uc
Journal:  Mov Disord       Date:  2012-06-28       Impact factor: 10.338

Review 5.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

Review 6.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

7.  The RBANS Effort Index: base rates in geriatric samples.

Authors:  Kevin Duff; Cynthia C Spering; Sid E O'Bryant; Leigh J Beglinger; David J Moser; John D Bayless; Kennith R Culp; James W Mold; Russell L Adams; James G Scott
Journal:  Appl Neuropsychol       Date:  2011-01

8.  Cognition in patients with newly diagnosed brain metastasis: profiles and implications.

Authors:  Adam Gerstenecker; Louis B Nabors; Karen Meneses; John B Fiveash; Daniel C Marson; Gary Cutter; Roy C Martin; Christina A Meyers; Kristen L Triebel
Journal:  J Neurooncol       Date:  2014-07-18       Impact factor: 4.130

9.  Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.

Authors:  Adam Gerstenecker; Benjamin Mast; Kevin Duff; Tanis J Ferman; Irene Litvan
Journal:  Arch Clin Neuropsychol       Date:  2012-11-04       Impact factor: 2.813

10.  Development of the Huntington disease work function scale.

Authors:  Bradley Brossman; Janet K Williams; Nancy Downing; James A Mills; Jane S Paulsen
Journal:  J Occup Environ Med       Date:  2012-10       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.